The Diagnostic Accuracy of Ultrasound in Assessment of Myometrial Invasion in Endometrial Cancer: Subjective Assessment versus Objective Techniques

Table 1

Demographic and clinical characteristics of 210 women with histologically confirmed endometrial cancer.

Characteristic	Value
Age (years)	66 (53; 83)
Body mass index (kg/m^2)	30 (21; 47)
Postmenopausal	193 (91.9)
Family history of breast and/or gynecological cancer	23 (10.9)
Current high/medium potency hormone use^1	12 (5.7)
Current low potency estrogen use^2	1 (0.5)
Current tamoxifen use	2 (0.9)
FIGO stage^3
IA	108 (51.4)
IB	56 (26.7)
II	18 (8.6)
IIIA	6 (2.9)
IIIB	0 (0.0)
IIIC1	8 (3.8)
IIIC2	8 (3.8)
IVA	0 (0.0)
IVB	6 (2.9)
Histological subtype and grade
Endometrioid adenocarcinoma, Grade 1	100 (47.6)
Endometrioid adenocarcinoma, Grade 2	59 (28.1)
Endometrioid adenocarcinoma, Grade 3	26 (12.4)
Nonendometrioid adenocarcinoma	25 (11.9)

Data are given as median (5th percentile; 95th percentile) for continuous variables; (%) for categorical variables. /dermal estradiol in combination with sequential or continuous progesterone. /vaginal estriol or vaginal estradiol. Federation of Gynecology and Obstetrics (FIGO) 2009 staging criteria.